Page last updated: 2024-08-25

maslinic acid and Bone Loss, Osteoclastic

maslinic acid has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, XL; Liu, M; Liu, T; Luo, J; Qiu, WW; Wei, G; Wu, Y1
Li, C; Li, D; Li, H; Li, Z; Liu, M; Luo, J; Ma, Y; Qian, M; Qiu, W; Tang, J; Wang, P; Wang, X; Wu, X; Yang, Z; Zhang, L; Zheng, C1

Other Studies

2 other study(ies) available for maslinic acid and Bone Loss, Osteoclastic

ArticleYear
Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption.
    European journal of medicinal chemistry, 2017, May-05, Volume: 131

    Topics: Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Diterpenes; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Molecular Structure; Osteogenesis; RANK Ligand; Structure-Activity Relationship

2017
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:3

    Topics: Actins; Animals; Biomarkers; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cell Line; Female; Gene Expression Regulation; Macrophage Colony-Stimulating Factor; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteogenesis; Ovariectomy; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; TNF Receptor-Associated Factor 6; Transcription Factor AP-1; Triterpenes

2011